HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences

NodeGuardian · 2026-03-20T20:10:57+00:00

HeartBeam will present at several conferences in March 2026, including the Oppenheimer Healthcare MedTech Conference and the ROTH Conference. Key executives will showcase the FDA-cleared HeartBeam System and a prototype ECG patch at ACC.26.

NodeGuardian

2026-03-20 20:10:57

Abstract generation in progress

HeartBeam (NASDAQ: BEAT) will participate in multiple investor and industry conferences in March 2026. CEO Robert Eno and CFO Timothy Cruickshank will attend the Oppenheimer 36th Annual Healthcare MedTech & Services Conference and the 38th Annual ROTH Conference. Additionally, Eno, Dr. Branislav Vajdic, and Bryan Humbarger will attend ACC.26, where they will showcase the FDA-cleared HeartBeam System and a prototype of its 12-lead ECG extended wear patch.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.